HCW Biologics Inc (HCWB)
1.13
-0.07
(-5.83%)
USD |
NASDAQ |
May 10, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
HCW Biologics Profit Margin (Quarterly): -806.7% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -806.7% |
September 30, 2023 | -578.9% |
June 30, 2023 | -691.1% |
March 31, 2023 | -12.11K% |
December 31, 2022 | -403.9% |
September 30, 2022 | -216.4% |
June 30, 2022 | -773.3% |
Date | Value |
---|---|
March 31, 2022 | -65.99% |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 50.27% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.11K%
Minimum
Mar 2023
50.27%
Maximum
Dec 2020
-1.73K%
Average
-578.9%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -19.35K% |
IGC Pharma Inc | -2.74K% |
NovaBay Pharmaceuticals Inc | -110.2% |
Protalix BioTherapeutics Inc | -57.64% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -91.92% |
Return on Assets | -64.43% |
Return on Invested Capital | -74.50% |
Gross Profit Margin (Quarterly) | 19.08% |
Operating Margin (Quarterly) | -813.3% |
Return on Net Operating Assets | -146.1% |